Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
159.82
+23.42 (17.17%)
Jun 9, 2025, 1:44 PM CST
451.67%
Market Cap 12.09B
Revenue (ttm) 488.02M
Net Income (ttm) -220.07M
Shares Out 88.60M
EPS (ttm) -2.33
PE Ratio n/a
Forward PE 227.33
Dividend 0.20 (0.15%)
Ex-Dividend Date n/a
Volume 4,360,236
Average Volume 3,934,428
Open 134.10
Previous Close 136.40
Day's Range 131.51 - 161.80
52-Week Range 22.94 - 159.82
Beta 1.54
RSI 61.46
Earnings Date Aug 29, 2025

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, mi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 1,036
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.